Advanced biosensing technology company B-Secur has announced a strategic partnership with cloud connectivity specialist Galen Data to provide advanced cardiac health monitoring for medical device manufacturers.

This collaboration aims to integrate B-Secur’s HeartKey Technology, a suite of ECG algorithms and analytics cleared by the US Food and Drug Administration (FDA), with Galen Data’s secure, compliant medical device cloud platform.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Galen Cloud is a configurable, scalable, and easy-to-use platform. It is designed to allow medical devices to centralise data and leverage cloud technologies.

The integration is designed to streamline software development, reduce costs, and mitigate operational risk for medical device companies.

B-Secur CCO Brian Pitstick said: “With the global cardiac monitoring market expected to reach $16bn by 2030, our partnership with Galen Data represents a timely and exciting leap forward in cardiac care technology solutions, merging clinical grade ECG algorithms with secure cloud connectivity to empower manufacturers and revolutionise patient monitoring.

“With this unique offering, Galen Data and B-Secur are poised to drive innovation and enhance the capabilities of cardiac health monitoring, providing a comprehensive and reliable platform for the future of cardiac care.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The partnership aims to provide enhanced cardiac health monitoring capabilities including accurate, seamless cloud integration, real-time monitoring, robust data management, and Electronic Health Records integration.

Galen Data COO Alex Condon said: “By combining our strengths, we are well-positioned to deliver a unique solution that not only meets the demands of cardiac device companies looking to leverage their data quickly and affordably but also showcases an end-to-end solution that truly highlights the potential of cloud-based medical device data platforms.

“This partnership is a perfect fit, enabling us to provide cardiac device manufacturers with unparalleled insights and capabilities right out of the box.”

Galen Data provides a secure, compliant software platform for medical device-to-cloud connectivity and data analysis compliant with FDA, HIPAA, CE Mark, and GDPR Standards.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact